Here are relevant reports on : poultry-medicine-market
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Virtual Care Market by Component (Software & Services, Hardware), Consultation Type (Video, Audio, Messaging), Application (Family Medicine, Internal Medicine, Pediatrics), End User (Hospital & Clinics, Pharmacies) & Region - Global Forecasts to 2030
The global virtual care market size is projected to reach $76.9 billion by 2030 from an estimated $8.4 billion in 2022, at a CAGR of 32.1%. The virtual care market is mainly driven by factors such as the increasing need to expand healthcare access especially in the rural areas, growing number of patient population worldwide, a shortage of physicians, advancements in telecommunications and the increasing adoption of digital healthcare services. However, regulatory disparity and reimbursement issues pertaining to virtual care are expected to restrain the growth of this market to a certain extent in the coming years.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping)-Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping) Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Animal Feed Additives Market (Pork, Beef, Veal & Poultry) - 2018 By Types, Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030
The Asia Pacific nucleic acid isolation and purification market, valued at USD1.49 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of USD2.65 billion by the end of the period. The Asia Pacific market for nucleic acid isolation and purification is expanding due to the increasing number of molecular tests and the scale-up of PCR and NGS across the region.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
